| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |